Guardant Health Q1 2024 Adj EPS $(0.94) Misses $(0.85) Estimate, Sales $168.500M Beat $150.673M Estimate
Portfolio Pulse from Benzinga Newsdesk
Guardant Health (NASDAQ:GH) reported Q1 2024 earnings with an adjusted EPS of $(0.94), missing the $(0.85) estimate, but sales of $168.5M exceeded the $150.673M estimate, marking a 30.91% increase from the previous year.
May 09, 2024 | 8:12 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Guardant Health reported a Q1 2024 adjusted EPS of $(0.94), missing estimates, but sales of $168.5M beat expectations, showing significant growth.
While the EPS miss might concern some investors, the significant beat on sales and the year-over-year growth are positive indicators. The mixed results could lead to neutral short-term stock price movement as investors weigh the earnings miss against the strong sales performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100